These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2105271)

  • 1. Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.
    Iacono-Connors LC; Schmaljohn CS; Dalrymple JM
    Infect Immun; 1990 Feb; 58(2):366-72. PubMed ID: 2105271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
    Iacono-Connors LC; Welkos SL; Ivins BE; Dalrymple JM
    Infect Immun; 1991 Jun; 59(6):1961-5. PubMed ID: 1903769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies.
    Iacono-Connors LC; Novak J; Rossi C; Mangiafico J; Ksiazek T
    Clin Diagn Lab Immunol; 1994 Jan; 1(1):78-82. PubMed ID: 7496927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.
    Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA
    J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.
    Barnard JP; Friedlander AM
    Infect Immun; 1999 Feb; 67(2):562-7. PubMed ID: 9916059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
    Gallagher TB; Mellado-Sanchez G; Jorgensen AL; Moore S; Nataro JP; Pasetti MF; Baillie LW
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007644. PubMed ID: 31430284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines.
    Gat O; Inbar I; Aloni-Grinstein R; Zahavy E; Kronman C; Mendelson I; Cohen S; Velan B; Shafferman A
    Infect Immun; 2003 Feb; 71(2):801-13. PubMed ID: 12540560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
    Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis.
    Rhie GE; Park YM; Chun JH; Yoo CK; Seong WK; Oh HB
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):331-9. PubMed ID: 16009541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity induced by Bacillus anthracis toxin-deficient strains.
    Pezard C; Weber M; Sirard JC; Berche P; Mock M
    Infect Immun; 1995 Apr; 63(4):1369-72. PubMed ID: 7890396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.
    Coulson NM; Fulop M; Titball RW
    Vaccine; 1994 Nov; 12(15):1395-401. PubMed ID: 7887017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a bivalent vaccine against anthrax and smallpox using the attenuated vaccinia virus KVAC103.
    Park DB; Ahn BE; Son H; Lee YR; Kim YR; Jo SK; Chun JH; Yu JY; Choi MM; Rhie GE
    BMC Microbiol; 2021 Mar; 21(1):76. PubMed ID: 33685392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE; Welkos SL; Knudson GB; Little SF
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins.
    Schmaljohn CS; Parker MD; Ennis WH; Dalrymple JM; Collett MS; Suzich JA; Schmaljohn AL
    Virology; 1989 May; 170(1):184-92. PubMed ID: 2655274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
    Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.